Reconsidering First-Line Therapy for Clarithromycin-Resistant Helicobacter pylori in Korea: The Role of Bismuth-Augmented Triple Therapy
versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection:
Authors
- Cheal Wung Huh (ORCID: https://orcid.org/0000-0001-7327-8503)
- Jae Kak Park (ORCID: https://orcid.org/0009-0000-0225-6729)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
Publication Details
- Journal
- Gut and Liver
- Published
- 2026-09-15
- DOI
- https://doi.org/10.5009/gnl260236
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00